Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR‐angiography at 3.0 tesla: Effects of contrast bolus length and flip angle-Reference-Cited by-同舟云学术

Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR‐angiography at 3.0 tesla: Effects of contrast bolus length and flip angle

Published:2016-11-10 Issue:6 Volume:45 Page:1617-1626
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Schubert Tilman¹²,Motosugi Utaroh¹³,Kinner Sonja¹⁴,Colgan Timothy J.¹,Sharma Samir D.¹,Hetzel Scott⁵,Wells Shane¹,Campo Camilo A.¹^ORCID,Reeder Scott B.¹⁶⁷⁸⁹

Affiliation:

1. Department of RadiologyUniversity of Wisconsin‐MadisonMadison Wisconsin USA

2. Clinic of Radiology and Nuclear MedicineBasel University HospitalBasel Switzerland

3. Department of RadiologyUniversity of YamanashiYamanashi Japan

4. Department of Diagnostic and Interventional Radiology and NeuroradiologyUniversity Hospital Essen Germany

5. Department of Biostatistics and Medical InformaticsUniversity of Wisconsin‐MadisonMadison Wisconsin USA

6. Department of Medical PhysicsUniversity of Wisconsin‐MadisonMadison Wisconsin USA

7. Department of MedicineUniversity of Wisconsin‐MadisonMadison Wisconsin USA

8. Department of Emergency MedicineUniversity of Wisconsin‐MadisonMadison Wisconsin USA

9. Department of Biomedical EngineeringUniversity of Wisconsin‐MadisonMadison Wisconsin USA

Funder

National Science Foundation

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.25513

Reference31 articles.

1. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

2. Ferumoxytol for Treating Iron Deficiency Anemia in CKD

3. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent

4. A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI;Prince MR;J Xray Sci Technol,2003

5. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guide to use of ferumoxytol for hepatic vascular assessment as part of dual contrast MRI;Pediatric Radiology;2023-08-21

2. Ferumoxytol-enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature;Abdominal Radiology;2021-03-05

3. Medical Applications of Magnetic Nanoparticles;New Trends in Nanoparticle Magnetism;2021

4. Iron Sucrose as MRI Contrast Agent in Ischemic Stroke Model;Journal of Magnetic Resonance Imaging;2020-02-29

5. Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry;Radiology;2020-01